The nonsteroidal anti-inflammatory drug (NSAID) flunixin meglumine has been approved by the FDA for fever associated with ...
Tennis365 on MSN21h
‘Prominent player’ Jannik Sinner under fire in PTPA legal documentsThe Professional Tennis Players Association has decided to take on the tennis "cartel" of the ATP, WTA, ITF and ITIA and "p" ...
AllTheThings.Best on MSN12h
Nuralogix Announces Anura MagicMirror to Say Who's Healthiest of AllNuralogix, a company recognized for its work in Affective AI, has introduced an upgraded version of its Anura MagicMirror.
Victory Capital Management Inc. raised its position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Free Report) by 112.8% during the fourth quarter, HoldingsChannel.com reports. The firm owned 211,130 ...
Corsair Pharma is planning a Phase 1 clinical trial of its treprostinil skin patch as a treatment for pulmonary arterial hypertension (PAH).
"The global industry was valued at US$ 37.0 Bn in 2023 and is projected to reach US$ 64.8 Bn by 2034, growing at a CAGR of ...
Cumberland Pharmaceuticals Inc. , a specialty pharmaceutical company with development efforts focused on rare diseases, today announced that results from its Phase 2 FIGHT DMD clinical trial were ...
In March 2025, Vertex Pharmaceuticals Incorporated announced a study is to evaluate the safety, and tolerability and efficacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback